Related Experiment Video

Updated: May 21, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K

Erratum: Nonphagocytic activation of NOX2 is implicated in progressive nonalcoholic steatohepatitis during aging

Joy X Jiang, Sarah R Fish, Alexey Tomilov

    Hepatology (Baltimore, Md.)
    |May 19, 2025
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
    08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    1.0K
    A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
    08:35

    A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

    Published on: May 18, 2021

    6.1K

    Related Experiment Videos

    Last Updated: May 21, 2025

    Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
    08:58

    Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

    Published on: March 11, 2017

    15.8K
    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
    08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    1.0K
    A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
    08:35

    A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

    Published on: May 18, 2021

    6.1K

    Related Concept Videos

    Inflammation01:38

    Inflammation

    52.1K
    Overview
    52.1K
    Liver Regeneration01:24

    Liver Regeneration

    3.2K
    The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
    Cells of Liver
    The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
    3.2K
    NF-κB-dependent Signaling Pathway02:26

    NF-κB-dependent Signaling Pathway

    7.2K
    The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
    NF-κB-dependent Signaling Mechanism
    The...
    7.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    Evaluation of Trichodysplasia Spinulosa Polyomavirus in Skin Biopsies, United States.

    Emerging infectious diseases·2026

    Caenorhabditis Intervention Testing Program: the putative mTOR inhibitors Cinnarizine and Meclizine do not extend lifespan in C. elegans.

    microPublication biology·2026

    Sarcomatoid malignancies with strong PD-L1 expression often represent dedifferentiated or undifferentiated melanomas.

    Human pathology·2026

    Mitral Valve Malignant Glomus Tumor Presenting With Multiple Embolic Events.

    JACC. Case reports·2026

    A good creator should be a wise listener: how user feedback impacts the performance of user-generated videos.

    Frontiers in psychology·2026

    Hyaluronan and CD44 targeting reverses early matrix changes, proinflammatory signals and fibrosis in primary sclerosing cholangitis.

    bioRxiv : the preprint server for biology·2026

    Reciprocal cross-species infection potential of human and domestic cat hepatitis B viruses.

    Hepatology (Baltimore, Md.)·2026

    The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology.

    Hepatology (Baltimore, Md.)·2026

    Safety and efficacy of zetomipzomib in relapsed or insufficiently responding autoimmune hepatitis: Results from the randomized, double-blind, placebo-controlled, phase 2a PORTOLA study and open-label extension.

    Hepatology (Baltimore, Md.)·2026

    Hepatitis B virus proteome analysis identifies apolipoprotein C1 facilitating particle production and virus entry.

    Hepatology (Baltimore, Md.)·2026

    Lactulose with or without TeleTai-Chi for the prevention of falls: A sequential multiple assignment randomized controlled trial (LiveSMART).

    Hepatology (Baltimore, Md.)·2026

    VPS13D protects against alcohol-associated steatohepatitis by regulating organelle contacts and VLDL secretion.

    Hepatology (Baltimore, Md.)·2026

    Epidemiology and Management of Neuroendocrine Neoplasms of Unknown Primary in Switzerland.

    Endocrine connections·2026

    Laparoscopic hemicolectomy with intracorporeal anastomosis for ascending colon cancer in situs inversus totalis: a case report and literature review.

    Frontiers in oncology·2026

    Contribution of Unspecified Brain Malignancies to Overall Brain Cancer Mortality Trends in the United States: A 26 years CDC WONDER Analysis.

    JPMA. The Journal of the Pakistan Medical Association·2026

    Comparative effectiveness and safety of upadacitinib versus vedolizumab in anti-TNF-exposed patients with ulcerative colitis.

    Inflammatory bowel diseases·2026

    Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

    Lancet (London, England)·2026

    [Special tumor entities : New results at the 2026 ASCO Annual Meeting].

    HNO·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us